Lv1
28 积分 2025-10-15 加入
Mazdutide versus placebo in Chinese adults with type 2 diabetes
1个月前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
1个月前
已完结
Chemoenzymatic Synthesis of Rhamnolipid-Modified Exendin-4: A Dual Approach for Long-Acting Glycemic Control through Endogenous Antibody Recruitment and Albumin Interaction
3个月前
已完结
Palmitic Acid Promotes Antiviral Innate Immunity via ZDHHC20-Mediated CMPK2 Palmitoylation
4个月前
已完结
The Preparation and Medical Applications of Chitosan Microspheres
5个月前
已完结
Oxyntomodulin - past, present and future
6个月前
已完结
Next generation dual GLP-1/GIP, GLP-1/glucagon, and triple GLP-1/GIP/glucagon agonists: a literature review
7个月前
已完结
Therapeutic potential of an old friend - the dichotomy of amylin in physiology and pathophysiology
7个月前
已关闭
Structure and biology of amylin
7个月前
已完结
Metformin: Up to Date
7个月前
已完结
皖公网安备34019202002308
